ClinicalTrials.Veeva

Menu

Vektor vMap™ Clinical Validation Study

V

Vektor Medical

Status

Completed

Conditions

Atrial Fibrillation
Premature Ventricular Complexes Multiple
Ventricular Fibrillation
Ventricular Arrythmia
Cardiac Arrhythmia
Premature Atrial Complex
Atrioventricular Reentrant Tachycardia
Ventricular Tachycardia

Treatments

Device: Cardiac ablation procedure

Study type

Observational

Funder types

Industry
Other

Identifiers

NCT04559061
20-PR-1010

Details and patient eligibility

About

This is a retrospective, multi center clinical study collecting existing, de-identified subject data from medical records to be analyzed using an independent core laboratory to validate performance of a computational ECG mapping system (vMap™).

Enrollment

225 patients

Sex

All

Ages

22 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patient has one of the following clinical arrhythmia/pacing types:

    • Atrial pacing
    • Atrial fibrillation
    • Ventricular pacing
    • Premature ventricular complex
    • Ventricular tachycardia
    • Ventricular fibrillation
    • Focal atrial tachycardia
    • Premature atrial complex
    • Atrioventricular reentrant tachycardia
  2. Patient has undergone 'successful' routine, standard of care diagnostic electrophysiology (EP) study using intracardiac catheters as clinically indicated, guided by fluoroscopy and routine electroanatomic mapping, intracardiac echocardiography, and/or cardiac imaging such as CT or MRI.

  3. Patient has 12 lead electrogram data of clinical rhythms recorded on electrogram recording system.

  4. Patient has undergone a successful ablation procedure.

  5. Arrhythmia type and atrial/ventricular characteristics can be abstracted from patient medical records.

  6. Patient was between 22 and 100 years of age at time of EP study and ablation procedure.

Exclusion criteria

Patients with unstable coronary artery disease, confirmed intracardiac thrombus, active sepsis, complex congenital heart disease, dextrocardia, severe pulmonary hypertension, decompensated heart failure, a mechanical heart valve, myocardial infarction within 1 month of ablation, inability to induce arrhythmia, unacceptable ECG data quality, and/or data included in the device training dataset.

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems